Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MedsRight is a healthcare technology company specializing in pharmacogenomics (PGx) and personalized medication management. The company provides genetic testing services that analyze how an individual's DNA affects their response to specific medications, aiming to reduce adverse drug reactions and improve therapeutic efficacy. By integrating genetic data with clinical decision support tools, MedsRight assists healthcare providers in optimizing drug selection and dosing for patients across various therapeutic areas, including mental health, cardiology, and pain management. Their services are designed to streamline the path to effective treatment while minimizing the trial-and-error approach often associated with prescribing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MedsRight.